Best Stocks To Buy In February 2024

In this article, we will disucss


As we step February 2024, investors should consider stocks in sectors exhibiting strong growth potential. Technology stocks remain promising, driven by ongoing advancements and digital transformation trends. Market conditions and economic indicators should be closely monitored for informed decisions. Additionally, diversifying a portfolio with a mix of growth and value stocks can help manage risks. Investors may benefit from staying informed about global events, economic policies, and industry developments to make well-informed decisions.

Market dynamics can change, so staying flexible and adapting to emerging opportunities is crucial for successful investing in February 2024.

List of Best Stocks to buy February 24

Sr. NoCompany NameBSE Scrip CodeNSE SymbolCMP
1Just Dial535648JUSTDIAL841.65
2Strides Pharma Science532531STAR686.3
3General Insurance Corporation of India540755GICRE352.65
4Paradeep Phosphates Ltd543530PARADEEP81.05

Detailed Overview of Best Stocks for Feb' 24

Just Dial

Just Dial Limited is India's number one Local Search engine that provides local search-related services to users across India through multiple platforms such as websites, mobile websites, Apps (Android, iOS, Windows), over the telephone, and text (SMS). As India’s no.1 local search engine, Justdial is a platform of solutions enabling businesses to become internet-ready and chart their path towards digital transformation. The diversified offerings for the company’s customers include a transaction-enabled and mobile-friendly website for SMEs, a rating tool for SMEs to solicit online ratings from their customers, and payment gateway solutions.

During Q2FY24, the company’s operating revenue and PAT surged by 20% and 23% YoY respectively. It is exploring the utilization of its data for analytics and cross-selling differentiated services to merchants. Just Dial is focused on growing traffic and monetization in both Tier 1 and Tier 2 cities.

The shares of the company have witnessed a surge in its delivery volume. One can buy the stock at … with a stop loss of 740.

Strides Pharma Science

Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. It is in the business of development and manufacturing of pharmaceutical products. The Company has a dedicated R&D facility in India with global filing capabilities and a strong footprint across 100 countries. The Company has two business verticals, viz., Regulated Markets and Emerging Markets. Regulated markets vertical comprises businesses in the United States, Europe, and Australia, emerging markets, primarily in Africa, and donor-funded institutional businesses. The emerging markets vertical includes African operations (except South Africa) and Institutional Business. The company has WHO pre-qualified manufacturing facility in Nairobi, Kenya.

Strides Pharma Science reported a strong Q2FY24 with the sixth consecutive quarter of absolute EBITDA growth and all-time high revenues. Strong order book in H2FY24 and several product approvals, including generic Vascepa, provide confidence for achieving higher end of revenue guidance.

As the shares of Strides Pharma have witnessed a surge in its delivery volume and is in momentum, one can buy the stock at … with a stop loss of 610.

General Insurance Corporation of India

General Insurance Corporation of India (GIC) is engaged in the business of Reinsurance. GIC Re was incorporated in November 1972, as a part of Government of India’s (GoI) move to nationalize the general insurance business. GIC Re is the largest player in India and leads most of the domestic companies' treaty programs and facultative placements. GIC Re is present in various segments of reinsurance, of which major segments are fire, health, motor, agriculture, marine, aviation and engineering.

The shares of GIC have witnessed a price-volume breakout with the stock rising more than 10% with heavy volumes. The stock is also in momentum in the last one year when compared to the Nifty 500. We recommend buying the stock at the current market price of … with a stop-loss of 292.

Paradeep Phosphates Ltd

Paradeep Phosphates Limited is primarily engaged in manufacturing, distribution, trading, and sales of a variety of complex fertilizers such as DAP, several grades of NPK, Zypmite and its by-product, Phospho-gypsum, and HFSA. It is also engaged in the distribution, trading, and sales of MOP, Ammonia, City compost, and P2O5-HSS. It is also engaged in the trading, distribution, and sales of Muriate of Potash (MOP), Ammonia, Speciality Plant Nutrients (SPN), and City compost. Its fertilizers are marketed under some of the key brand names in the market ‘Jai Kisaan - Navratna’ and ‘Navratna’.

The company has a manufacturing facility located in Paradeep, Odisha, and includes a DAP and NPK production facility, a Sulphuric acid production plant, and a Phosphoric acid production plant. It reported strong financial numbers in Q2FY24, with significant year-on-year growth in revenue, EBITDA, and profit after tax.

The company has been able to deliver an ROE and ROCE of 11 percent each. The shares of the company are witnessing a surge in its delivery volume. One can buy the stock at … with a stop loss of 71.


 CMS Infosystems Ltd is the only and largest integrated banking solutions provider with end-to-end offerings. The company is engaged in installing, maintaining, and managing assets for banks, financial institutions, and organized retail and e-commerce companies in India. Serving across more than 16K pin codes at PAN India Level. Managed Services & Technology Solutions include Banking Automation, ATM-as-a-Service, ALGO Software, and AIoT Remote Monitoring.

Cash Logistics contributes 60% to the total revenues earned by the entity and the balance is from Managed Services & Technology Solutions as of Q3FY24.

It announced its Q3FY24 results and has performed exceptionally despite headwinds such as an exponential rise in UPI’s and other cashless transfers.

The company’s Debt-equity ratio stands at just 0.11 and with Price to Earnings ratio of 19.1 which is below its 5-year Median PE of 20. Q3FY24 recorded the highest year standalone revenues and PAT which grew at 19% and 22% YoY. The stock is trading close to its all-time highs and is in momentum. One can buy this stock at Rs. 390 levels with a stop loss of Rs. 340.

Disclaimer: INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING. The asset classes and securities quoted in the film are exemplary and are not recommendatory. SAMCO Securities Limited (Formerly known as Samruddhi Stock Brokers Limited): BSE: 935 | NSE: 12135 | MSEI- 31600 | SEBI Reg. No.: INZ000002535 | AMFI Reg. No. 120121 | Depository Participant: CDSL: IN-DP-CDSL-443-2008 CIN No.: U67120MH2004PLC146183 | SAMCO Commodities Limited (Formerly known as Samruddhi Tradecom India Limited) | MCX- 55190 | SEBI Reg. No.: INZ000013932 Registered Address: Samco Securities Limited, 1004 - A, 10th Floor, Naman Midtown - A Wing, Senapati Bapat Marg, Prabhadevi, Mumbai - 400 013, Maharashtra, India. For any complaints Email - Research Analysts -SEBI Reg.No.-INHO0O0005847

Download App to know your Andekha Sach

Get the link to download the app.

Google Play Store App Store
Samco Fast Trading App

Leave A Comment?